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Sir,
Diet is thought to be one of the most important contributing
factors to cancer risk (Bingham and Riboli, 2004). Among the dietary
improvements that can reduce the risk of cancer, Stein and Colditz
(2004) highlighted the promising relationship between prostate
cancer and tomatoes intake. Here, we wish to draw attention to
Allium vegetables (i.e. garlic and onion), which, on the basis of
epidemiological studies, have been showing promising signs of
possessing chemopreventive activity in patients with prostate cancer.
Garlic (Allium sativum) and onion (Allium cepa) are among the
oldest of all cultivated plants and now used as a food and for medical
purpose (e.g. garlic for hypercholesterolaemia and hypertension)
(Capasso et al, 2003). Site-specific, case–control studies and cohort
studies suggest a preventive effect of Allium vegetables consumption
against stomach, colorectal and prostate cancer, although evidence
for a protective effect against cancer at other sites, including the
breast, is still lacking (Ernst, 2000). Most notably, a population-
based, case–control study, performed on 238 patients with prostate
cancer and 471 male control subjects, investigated the association
between intake of Allium vegetables and the risk of prostate cancer
(Hsing et al, 2002). It was found that men in the category of highest
intake of Allium vegetables (410gday
1) had a statistically
significant lower risk of contracting prostate cancer than did those
in the category of lowest intake (2.2gday
1). The reduced risk of
prostate cancer associated with Allium vegetables was independent
of body size, intake of other foods and total calorie intake, and was
more pronounced for men with localized than with advanced
prostate cancer (Hsing et al, 2002).
Experimental studies have shown that the chemopreventive
activity of Allium vegetables is related to their content of
organosulphur compounds (OSCs). Although how these compounds
achieve chemoprevention is not fully understood, several modes of
action have been proposed (Knowles and Milner,
2001; Griffiths et al, 2002; Rahman, 2003; Thomson and Ali,
2003). These include: (i) effect on drug metabolising enzymes
(i.e. induction of phase II detoxification enzymes, including
glutathione transferases, quinine reductase, epoxide hydrolase and
glucuronosyl transferase, that inactivate toxic substances
and facilitate their excretion); (ii) antioxidant activity (garlic
preparations exhibit radical scavenging activity and decrease
lipid peroxidation, which is relevant in the light of the observation
that tumour promotion may involve oxygen radicals); (iii) tumour
growth inhibition that has been documented in several carcinoma
cell lines, including prostate carcinoma cells; (iv) induction of
apoptosis, which coincides with an increase in the percentage of
cells blocked in the G2/M phase of the cell cycle (possibly through a
depression in p34
cdc2 kinase); and (v) effective stimulation of the
immune response (OSCs stimulates proliferation of lymphocytes
and macrophage phagocytosis, induce the infiltration of macro-
phages and lymphocytes in transplanted tumours, induce splenic
hypertrophy, stimulate release of interleukin-2, tumour necrosis
factor-a and interferon-g, enhance natural killer cell, killer cell and
lymphokine-activated killer cell activity).
In conclusion, promising data from clinical studies suggest that
the regular consumption of garlic and onion may prevent prostate
cancer. Allium-derived organosulphoric compounds may be
responsible, at least in part, for the anticarcinogenic activity. The
unique property of garlic and onion may be clinically important,
because their daily intake for a prolonged period is expected to be
free of risk.
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